These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 25647404)

  • 1. How do I manage Rh typing in obstetric patients?
    Haspel RL; Westhoff CM
    Transfusion; 2015 Mar; 55(3):470-4. PubMed ID: 25647404
    [No Abstract]   [Full Text] [Related]  

  • 2. Do we need to be more concerned about weak D antigens?
    Garratty G
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfusion medicine illustrated: blocked D phenomenon.
    Moiz B; Salman M; Kamran N; Shamsuddin N
    Transfusion; 2008 Aug; 48(8):1545-6. PubMed ID: 18713103
    [No Abstract]   [Full Text] [Related]  

  • 4. An unusual false-positive fetal RHD typing result using DNA derived from maternal plasma from a solid organ transplant recipient.
    Minon JM; Senterre JM; Schaaps JP; Foidart JM
    Transfusion; 2006 Aug; 46(8):1454-5. PubMed ID: 16934085
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anti-Rho[D] antigen monoclonal antibodies. II. Serological characteristics of monoclonal IgG1 antibodies].
    Olovnikova NI; Belkina EV; Lemeneva LN; Berkovskiĭ AL; Deriugina EI; Chertkov IL
    Gematol Transfuziol; 1992; 37(9-10):5-9. PubMed ID: 1490578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The introduction of human monoclonal anti-D for therapeutic use.
    Fletcher A; Thomson A
    Transfus Med Rev; 1995 Oct; 9(4):314-26. PubMed ID: 8541714
    [No Abstract]   [Full Text] [Related]  

  • 7. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive prenatal determination of fetal RhD genotyping from maternal plasma: a preliminary study in Pakistan.
    Mohammed N; Kakal F; Somani M; Zafar W
    J Coll Physicians Surg Pak; 2010 Apr; 20(4):246-9. PubMed ID: 20392400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a rapid antenatal Rh test on laboratory testing.
    Smart EA; Milner LV
    S Afr Med J; 1993 Dec; 83(12):922. PubMed ID: 8115932
    [No Abstract]   [Full Text] [Related]  

  • 10. When is an anti-D antibody not an anti-D antibody?
    Merron BM; Maguire K; Morris K
    Transfus Med; 2015 Apr; 25(2):115-7. PubMed ID: 25925731
    [No Abstract]   [Full Text] [Related]  

  • 11. Rh haemolytic disease of the newborn and Rh genotyping by RFLP--and allele-specific--PCR.
    Le Van Kim C; Colin Y; Brossard Y; Cartron JP
    Transfus Clin Biol; 1995; 2(4):317-24. PubMed ID: 8542030
    [No Abstract]   [Full Text] [Related]  

  • 12. Gm typing, IgG subclasses of anti-Rh(D) and severity of hemolytic disease of the newborn.
    Alie-Daran SJ; Dugoujon JM; Fournie A
    Vox Sang; 1992; 62(2):127-8. PubMed ID: 1519368
    [No Abstract]   [Full Text] [Related]  

  • 13. [The importance of laboratory diagnosis in allo-immunization through pregnancy and hemolytic disease of the newborn].
    Florea DP
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):211-3. PubMed ID: 20509304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance between fetal RhD typing using molecular methods and neonatal typing with serology.
    Van Den Veyver IB; Yankowitz J; Subramanian SB; Dorman KF; Moise KJ
    Gynecol Obstet Invest; 1999; 48(4):229-31. PubMed ID: 10592422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More on the R0 Har antigenic complex.
    Case J
    Transfusion; 1996; 36(11-12):1034-5. PubMed ID: 8937417
    [No Abstract]   [Full Text] [Related]  

  • 16. [Alloimmunization to a high frequency Rh antigen].
    Cotorruelo C; Biondi C; Borras SG; Racca L; Brunetti D; Di Monaco R; Racca A
    Medicina (B Aires); 2006; 66(1):46-8. PubMed ID: 16555729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.
    Sandler SG; Flegel WA; Westhoff CM; Denomme GA; Delaney M; Keller MA; Johnson ST; Katz L; Queenan JT; Vassallo RR; Simon CD;
    Transfusion; 2015 Mar; 55(3):680-9. PubMed ID: 25438646
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemolytic disease of the newborn caused by anti-c antibodies. Case report].
    Ornat K; Cyran T; Maszkiewicz W
    Acta Haematol Pol; 1988; 19(1-2):75-6. PubMed ID: 3149114
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-c antibodies as a cause of severe form of hemolytic disease of the newborn].
    Sławek Z; Stolarz E; Banaszkiewicz A; Walczak Z; Surowiec E
    Acta Haematol Pol; 1988; 19(1-2):71-4. PubMed ID: 3149113
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.